Post Marketing Surveillance Study of Cuprimine

Merck Sharp & Dohme (MSD)

Status

Conditions

Scleroderma

Treatments

Drug: Cuprimine (penicillamine)

Study type

Expanded Access

Funder types

Industry

Identifiers

NCT01374282

0172-001

Details and patient eligibility

About

Cuprimine (penicillamine) was made available in the Philippines by the Sponsor under a Compassionate Special Permit issued by the Bureau of Food and Drugs. Physicians were able to request the drug for their patients from the Sponsor. A Clinical Study Report form was completed for each purchase of Cuprimine.

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria